Vijaya Diagnostic Centre Limited has made a regulatory disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding board appointments.

The Board of Directors of the Company, through a Circular Resolution, has appointed two new Additional Directors in the capacity of Non-Executive Independent Directors:

Appointment Details

  • Mr. Satyanaryana Murthy Chavali (DIN: 00142138): Appointed for a term of 5 consecutive years with effect from May 26, 2026
  • Mr. Dipinder Singh Sekhon (DIN: 01000924): Appointed for a term of 2 consecutive years with effect from May 26, 2026

Both appointments are subject to the approval of the shareholders of the Company.

Director Profiles and Qualifications

Mr. Satyanaryana Murthy Chavali:

  • Holds a Bachelor of Technology degree from Indian Institute of Technology Madras
  • Holds a Post Graduate Diploma in Management from Indian Institute of Management Bangalore
  • Extensive experience in pharmaceutical and life sciences industry
  • Previously served as Chief Executive Officer of Aurigene Discovery Technologies Limited
  • Held senior leadership positions at Dr. Reddy's Laboratories Limited
  • Expertise in pharmaceutical research and development, drug discovery, strategic leadership, business operations, corporate governance, and management of large organisations

Mr. Dipinder Singh Sekhon:

  • Technology entrepreneur, innovator, and AI strategist with over two decades of experience
  • Expertise in artificial intelligence, computer vision, medical imaging, and enterprise technology leadership
  • Founder of iKITES.ai and Ophthal.ai initiatives under the 'Knowledge Innovation and Technology EcoSystem (KITES)' vision
  • Co-Founder of KritiKal Solutions (2002), scaling it into a multi-million-dollar enterprise delivering AI-powered solutions
  • Associated with Indian Institute of Technology Delhi and its Foundation for Innovation and Technology Transfer (FITT)
  • Holds a Bachelor of Technology degree from Indian Institute of Technology Delhi
  • Pursued public and economic policy studies at Sciences Po and London School of Economics and Political Science
  • Currently pursuing executive education at Harvard Medical School
  • Engaged in technology leadership, innovation, startup incubation, and venture building across healthcare, mobility, manufacturing, and education sectors

Regulatory Compliance Disclosures

  • Both directors are not related to any existing Director on the Board of the Company
  • Neither director is debarred from holding the office of director pursuant to any SEBI order or any other authority
  • The disclosure complies with BSE circular ref no. LIST/COMP/14/2018-19 and National Stock Exchange of India Limited ref no. NSE/CML/2018/24 dated June 20, 2018
  • The intimation references SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026

The disclosure was signed by Ankit Shah, Chief Financial Officer, on May 25, 2026 at 18:24:59 +05'30'.